• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物及天然来源成分在婴儿严重肌阵挛性癫痫(德拉韦特综合征)中的活性

Activity of drugs and components of natural origin in the severe myoclonic epilepsy of infancy (Dravet syndrome).

作者信息

Berio Agostino, Piazzi Attilia

机构信息

Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), University of Genova, Largo Gaslini 5, Genova, Italy.

出版信息

Cent Nerv Syst Agents Med Chem. 2015;15(2):95-8. doi: 10.2174/1871524915666150430161321.

DOI:10.2174/1871524915666150430161321
PMID:25924876
Abstract

The sea anemones (Cnidaria) produce neurotoxins, polypeptides active on voltage-gated sodium channels, which induce a non-inactivating condition, with consequent seizures and paralysis in zebrafish (Danio rerio). In humans, severe myoclonic epilepsy of infancy (SMEI) is due to SCN1A gene mutation, which causes a non-inactivating sodium channels condition with seizures. Some symptoms, such as age of first seizure, repetitive events, frequent status epilepticus, scarce responsiveness to antiepileptic drugs (AEDs), may be due to superimposed environmental causes. The authors report a case of SMEI treated for years with benzodiazepines and subsequently with valproate. The attenuation of the frequency of epileptic events and of time in seizing, but no change in burst duration and EEG events was observed. These results are similar to those reported in the literature about zebrafish scn1Lab mutant, which recapitulates the SCN1A symptoms and AED resistance occurring in humans. During seizures the production of polypeptides similar to sea anemones neurotoxins, causing repetitive seizures, status epilepticus, and AED resistance can be hypothesized in subjects with SCN1A mutation.

摘要

海葵(刺胞动物门)会产生神经毒素,即对电压门控钠通道有活性的多肽,这些多肽会诱发一种非失活状态,进而导致斑马鱼(斑马丹鱼)出现癫痫发作和麻痹。在人类中,婴儿严重肌阵挛性癫痫(SMEI)是由SCN1A基因突变引起的,该突变会导致钠通道处于非失活状态并引发癫痫发作。一些症状,如首次癫痫发作的年龄、反复出现的事件、频繁的癫痫持续状态、对抗癫痫药物(AEDs)反应不佳,可能是由叠加的环境因素导致的。作者报告了一例多年来一直使用苯二氮䓬类药物治疗,随后使用丙戊酸盐治疗的SMEI病例。观察到癫痫发作频率和发作时间有所减轻,但发作持续时间和脑电图事件没有变化。这些结果与文献中关于斑马鱼scn1Lab突变体的报道相似,该突变体概括了人类中出现的SCN1A症状和对AEDs的耐药性。在癫痫发作期间,可以推测在患有SCN1A突变的受试者中会产生类似于海葵神经毒素的多肽,从而导致反复癫痫发作、癫痫持续状态和对AEDs耐药。

相似文献

1
Activity of drugs and components of natural origin in the severe myoclonic epilepsy of infancy (Dravet syndrome).药物及天然来源成分在婴儿严重肌阵挛性癫痫(德拉韦特综合征)中的活性
Cent Nerv Syst Agents Med Chem. 2015;15(2):95-8. doi: 10.2174/1871524915666150430161321.
2
NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome.NaV1.1 和 NaV1.6 选择性化合物可减少新型 Dravet 综合征斑马鱼模型的行为表型和癫痫样活动。
PLoS One. 2020 Mar 5;15(3):e0219106. doi: 10.1371/journal.pone.0219106. eCollection 2020.
3
New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome.对 Dravet 综合征斑马鱼模型中癫痫发生早期机制的新认识。
Epilepsia. 2020 Mar;61(3):549-560. doi: 10.1111/epi.16456. Epub 2020 Feb 24.
4
Behavioral Comorbidities and Drug Treatments in a Zebrafish Model of Dravet Syndrome.行为共病和药物治疗在德拉维特综合征斑马鱼模型中的研究。
eNeuro. 2017 Aug 14;4(4). doi: 10.1523/ENEURO.0066-17.2017. eCollection 2017 Jul-Aug.
5
Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.Dravet综合征反义敲低斑马鱼模型的药理学特征:血清素激动剂芬氟拉明对癫痫发作的抑制作用
PLoS One. 2015 May 12;10(5):e0125898. doi: 10.1371/journal.pone.0125898. eCollection 2015.
6
Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.Scn1a 斑马鱼突变体中的药物筛选鉴定 Clemizole 为潜在的 Dravet 综合征治疗药物。
Nat Commun. 2013;4:2410. doi: 10.1038/ncomms3410.
7
Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.抗癫痫药物治疗不同基因型Dravet综合征的疗效。
Brain Dev. 2016 Jan;38(1):40-6. doi: 10.1016/j.braindev.2015.06.008. Epub 2015 Jul 13.
8
[Clinical features and SCN1A gene mutation analysis of severe myoclonic epilepsy of infancy].婴儿严重肌阵挛癫痫的临床特征及SCN1A基因突变分析
Zhonghua Er Ke Za Zhi. 2008 Oct;46(10):769-73.
9
Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?与涉及SCN1A基因的2号染色体2q24.3缺失相关的癫痫表型:婴儿期游走性部分性发作还是非典型Dravet综合征?
Epilepsy Res. 2015 Jan;109:34-9. doi: 10.1016/j.eplepsyres.2014.10.008. Epub 2014 Oct 28.
10
The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.电压门控钠通道Scn8a是婴儿严重肌阵挛性癫痫的一种遗传修饰因子。
Hum Mol Genet. 2007 Dec 1;16(23):2892-9. doi: 10.1093/hmg/ddm248. Epub 2007 Sep 19.

引用本文的文献

1
Use of Zebrafish Models to Boost Research in Rare Genetic Diseases.利用斑马鱼模型促进罕见遗传疾病研究。
Int J Mol Sci. 2021 Dec 12;22(24):13356. doi: 10.3390/ijms222413356.
2
Natural Medicines for the Treatment of Epilepsy: Bioactive Components, Pharmacology and Mechanism.用于治疗癫痫的天然药物:生物活性成分、药理学及作用机制
Front Pharmacol. 2021 Mar 4;12:604040. doi: 10.3389/fphar.2021.604040. eCollection 2021.